CAG

Description

CAG

Description:
CAG is a long-acting analog of the naturally occurring hormone amylin, designed for research into energy balance, appetite regulation, and metabolic health. This peptide acts as an amylin receptor agonist, supporting studies on satiety signaling, delayed gastric emptying, and reduced food intake. Its extended half-life and stability make it a useful candidate for exploring synergistic effects when combined with GLP-1 receptor agonists such as SMG-1 or TZP-2 in research models.

Appearance: Lyophilized powder
Storage: Store dry at 2–8°C. Once reconstituted, store at 2–8°C and use within 30 days.
Solubility: Soluble in bacteriostatic water (BAC water) or sterile water for injection (SWFI).

Research Focus Areas:

• Appetite and energy homeostasis studies
• Obesity and metabolic regulation
• Combination peptide therapy exploration (e.g., GLP-1 + Amylin analog)
• Gastrointestinal motility and glucose metabolism research

Disclaimer:

• For Research Use Only. Not for human consumption, medical, or veterinary use.
• This product is intended solely for in vitro or laboratory animal research.
• Not approved by the FDA, EMA, or any regulatory agency for diagnostic, therapeutic, or cosmetic use.
• All product information is provided for educational and research purposes only.
• Handling and use should be performed only by qualified professionals in a controlled laboratory setting.